Condition
Neurodevelopmental Delay
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Recruiting2
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06893939Phase 2Recruiting
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
NCT06315699Phase 2Completed
Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome
NCT04815889Not ApplicableRecruiting
Early Detection and Intervention in Developmental Delay / Behavioral Problems in Preschool Children - PLUSS
NCT06367062Not Yet RecruitingPrimary
General Anesthesia/Surgical Exposure on White Matter Development in Children
NCT00457990Not ApplicableCompleted
Neurodevelopment After Early Iron Supplementation
Showing all 5 trials